Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Rustin

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Forum (Genoa, Italy)|September 6, 2001
Circulating tumour markers in ovarian tumoursM von Schlippe, G J Rustin
BJU International|September 6, 2000
Diagnostic delay and risk of relapse in patients with stage I nonseminomatous germ cell tumour followed on active surveillanceM P Napier, G J Rustin
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
How long should first-line chemotherapy continue?K Bertelsen, S Grenman, G J Rustin
BMJ (Clinical Research Ed.)|October 29, 1988
Don't ignore a positive pregnancy testD B Smith, G J Rustin, K D Bagshawe
Cancer Chemotherapy and Pharmacology|January 1, 1986
Acute neurological toxicity of intrathecal cytosine arabinoside. A case reportS M Crawford, G J Rustin, K D Bagshawe
British Journal of Cancer|June 1, 1990
Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumoursM J Seckl, G J Rustin, K D Bagshawe
British Journal of Cancer|November 1, 1992
CA-125 is not a useful marker in metastatic breast cancerM J Seckl, G J Rustin, R C Coombes
Journal of Cell Science|April 1, 1979
Studies on the subcellular localization of human neutrophil alkaline phosphataseG J Rustin, P D Wilson, T J Peters
British Journal of Cancer|August 1, 1996
Phase I trial of elactocinE S Newlands, G J Rustin, M H Brampton
The Histochemical Journal|January 1, 1981
The ultrastructural localization of human neutrophil alkaline phosphatase in normal individuals during pregnancy and in patients with chronic granulocytic leukaemiaP D Wilson, G J Rustin, T J Peters
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Forum (Genoa, Italy)|September 6, 2001
Circulating tumour markers in ovarian tumoursM von Schlippe, G J Rustin
BJU International|September 6, 2000
Diagnostic delay and risk of relapse in patients with stage I nonseminomatous germ cell tumour followed on active surveillanceM P Napier, G J Rustin
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
How long should first-line chemotherapy continue?K Bertelsen, S Grenman, G J Rustin
BMJ (Clinical Research Ed.)|October 29, 1988
Don't ignore a positive pregnancy testD B Smith, G J Rustin, K D Bagshawe
Cancer Chemotherapy and Pharmacology|January 1, 1986
Acute neurological toxicity of intrathecal cytosine arabinoside. A case reportS M Crawford, G J Rustin, K D Bagshawe
British Journal of Cancer|June 1, 1990
Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumoursM J Seckl, G J Rustin, K D Bagshawe
British Journal of Cancer|November 1, 1992
CA-125 is not a useful marker in metastatic breast cancerM J Seckl, G J Rustin, R C Coombes
Journal of Cell Science|April 1, 1979
Studies on the subcellular localization of human neutrophil alkaline phosphataseG J Rustin, P D Wilson, T J Peters
British Journal of Cancer|August 1, 1996
Phase I trial of elactocinE S Newlands, G J Rustin, M H Brampton
The Histochemical Journal|January 1, 1981
The ultrastructural localization of human neutrophil alkaline phosphatase in normal individuals during pregnancy and in patients with chronic granulocytic leukaemiaP D Wilson, G J Rustin, T J Peters
Pageof 16